Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07884734Phase 1Active, not recruiting
Phase 1, open-label trial of radiprodil (2 arms), sponsored by GRIN Therapeutics, Inc. Primary endpoints: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration, Area Under the Plasma Concentration-Time Curve From Time Zero Extrapolated to Infinity and 1 more. Started Jun 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07884734.